Time point | Study period November 4, 2019–April 30, 2021 | ||
---|---|---|---|
Day 1 | Week 2 | Week 6 | |
Enrolment | |||
Medical history and physical examination | X | ||
Explanation of the study and informed consent | X | ||
Initial CRF | X | ||
Giving out of the symptom diary, up to week 2 | X | ||
Interventions | |||
CRP rapid test if needed (only among those patients visited by professionals assigned to the CRP intervention groups)* | X | ||
Use of an interactive booklet (only among those patients visited by professionals assigned to the enhanced communication skill intervention groups)* | X | ||
Assessments | |||
Assessment of the clinical outcome | X | X | |
Collection and review of the symptom diary | X | ||
EQ-5D-5L questionnaire | X | X | X |
Antibiotic consumption | X | X | X |
Use of drugs other than antibiotics | X | X | X |
Tests ordered by clinicians | X | X | X |
Patient satisfaction with care | X | X | |
Patient perception of the usefulness of the information received | X | X | |
Patient future consulting intentions | X | X | |
Absenteeism | X | X | X |
Evaluation of adverse events | X | X | |
Number of re-consultations to primary and secondary care and number of complications regarding the ALRTI | X |